Netherton Investments is an investment fund operating on behalf of Mike Platt.
Portfolio
1
companies
Mike Platt
Investor Director
The financing was provided by Netherton Investments to advance extracellular matrix-targeted treatments for solid tumours and fibrosis.
"Closing this financing strengthens our ability to translate Engitix's unique ECM understanding into a growing pipeline of targeted therapeutics."
The financing round was co-led by Netherton Investments and Dompé farmaceutici.
"Our mission is to improve people’s lives and we partner with the best academic and industrial groups to accelerate the research that will bring new solutions to patients’ unmet needs. We look forward to working with the Engitix team to combine the power of Exscalate with Engitix’s deep understanding of the biology of the fibrosis and solid tumours microenvironment and the unique strength of its ECM platform. Our collaboration will enable us to accelerate the clinical translation of targets beyond our four key in-house therapeutic areas of ophthalmology, metabolic disorders, oncology, and pain management."
